These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 28030591)
41. The C-terminal α-helices of mammalian Hsc70 play a critical role in the stabilization of α-synuclein binding and inhibition of aggregation. Chaari A; Eliezer D; Ladjimi M Int J Biol Macromol; 2016 Feb; 83():433-41. PubMed ID: 26601760 [TBL] [Abstract][Full Text] [Related]
42. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Peelaerts W; Bousset L; Van der Perren A; Moskalyuk A; Pulizzi R; Giugliano M; Van den Haute C; Melki R; Baekelandt V Nature; 2015 Jun; 522(7556):340-4. PubMed ID: 26061766 [TBL] [Abstract][Full Text] [Related]
43. Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies. Sengupta U; Guerrero-Muñoz MJ; Castillo-Carranza DL; Lasagna-Reeves CA; Gerson JE; Paulucci-Holthauzen AA; Krishnamurthy S; Farhed M; Jackson GR; Kayed R Biol Psychiatry; 2015 Nov; 78(10):672-83. PubMed ID: 25676491 [TBL] [Abstract][Full Text] [Related]
44. The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity. Xu CK; Castellana-Cruz M; Chen SW; Du Z; Meisl G; Levin A; Mannini B; Itzhaki LS; Knowles TPJ; Dobson CM; Cremades N; Kumita JR Molecules; 2022 Feb; 27(4):. PubMed ID: 35209093 [TBL] [Abstract][Full Text] [Related]
45. Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease? Schulz-Schaeffer WJ Biomolecules; 2015 Jul; 5(3):1467-79. PubMed ID: 26193328 [TBL] [Abstract][Full Text] [Related]
46. Dimerization propensities of Synucleins are not predictive for Synuclein aggregation. Eckermann K; Kügler S; Bähr M Biochim Biophys Acta; 2015 Aug; 1852(8):1658-64. PubMed ID: 25960149 [TBL] [Abstract][Full Text] [Related]
47. Tau Interacts with the C-Terminal Region of α-Synuclein, Promoting Formation of Toxic Aggregates with Distinct Molecular Conformations. Dasari AKR; Kayed R; Wi S; Lim KH Biochemistry; 2019 Jun; 58(25):2814-2821. PubMed ID: 31132261 [TBL] [Abstract][Full Text] [Related]
51. Following the fate of endocytosed fibrils. Hasegawa M; Suzuki G J Biol Chem; 2017 Aug; 292(32):13498-13499. PubMed ID: 28801354 [TBL] [Abstract][Full Text] [Related]
53. Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein-induced toxicity. Emadi S; Barkhordarian H; Wang MS; Schulz P; Sierks MR J Mol Biol; 2007 May; 368(4):1132-44. PubMed ID: 17391701 [TBL] [Abstract][Full Text] [Related]
54. Fibril growth and seeding capacity play key roles in α-synuclein-mediated apoptotic cell death. Mahul-Mellier AL; Vercruysse F; Maco B; Ait-Bouziad N; De Roo M; Muller D; Lashuel HA Cell Death Differ; 2015 Dec; 22(12):2107-22. PubMed ID: 26138444 [TBL] [Abstract][Full Text] [Related]
55. Lipid peroxidation product 4-hydroxy-2-nonenal promotes seeding-capable oligomer formation and cell-to-cell transfer of α-synuclein. Bae EJ; Ho DH; Park E; Jung JW; Cho K; Hong JH; Lee HJ; Kim KP; Lee SJ Antioxid Redox Signal; 2013 Mar; 18(7):770-83. PubMed ID: 22867050 [TBL] [Abstract][Full Text] [Related]
56. Targeting intracellular and extracellular alpha-synuclein as a therapeutic strategy in Parkinson's disease and other synucleinopathies. Vekrellis K; Stefanis L Expert Opin Ther Targets; 2012 Apr; 16(4):421-32. PubMed ID: 22480256 [TBL] [Abstract][Full Text] [Related]